Detalles de la búsqueda
1.
Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy.
Oncologist
; 2023 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38035767
2.
Lenvatinib with or Without Everolimus in Patients with Metastatic Renal Cell Carcinoma After Immune Checkpoint Inhibitors and Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapies.
Oncologist
; 26(6): 476-482, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33792094
3.
Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy.
Eur Urol Focus
; 9(5): 734-741, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36863962
4.
Safe and effective use of nivolumab plus ipilimumab in a patient with metastatic clear-cell renal cell carcinoma with sarcomatoid dedifferentiation and end stage renal disease on hemodialysis.
Cancer Treat Res Commun
; 27: 100349, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33725559
5.
Efficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinoma.
Clin Genitourin Cancer
; 19(6): e401-e408, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34625389
6.
Efficacy and Safety of Bevacizumab Plus Erlotinib in Patients with Renal Medullary Carcinoma.
Cancers (Basel)
; 13(9)2021 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33946504
Resultados
1 -
6
de 6
1
Próxima >
>>